c4 therapeutics inc.

c4 therapeutics inc.

NASDAQ:CCCC
C4 Therapeutics Inc.

Chart

Detailed Quote

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Featured Articles and Interviews
Press Releases

C4 Therapeutics Presents Phase 1 Data at European Hematology Association 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

C4 Therapeutics to Participate in Upcoming Conferences

C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

The Conversation (0)